Floatz logo

Enoxaparin

Pulmonary Embolism

Medical University of Gdanskother_biologicalPhase 1/2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Pulmonary Embolism cohort.

Asset / SponsorPhaseRating
Apixaban
Medical University of Gdansk
Phase 3BB
Tranexamic Acid
Albert Einstein College of Medicine
Phase 4BB
Fondaparinux
Johns Hopkins University
Phase 2BB
Heparin
Johns Hopkins University
Phase 4B
Helium
Thunder Bay Regional Health Research Institute
Early Phase 1C

View all 13 →

Same molecule, other indications

Enoxaparin is also rated in:

thrombophlebitisDormant
BBB
Indicative · Phase 3
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative · Phase 4
67 / 100
View asset →
thrombotic diseaseActive
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →